SECTOR
USFDA completes inspection at SMS Lifesciences’ API manufacturing facility in Telangana
May-09-2025

United States Food and Drug Administration (USFDA) has completed inspection at SMS Lifesciences India’s API manufacturing facility located at Sy. No. 180/2, Kazipally (V) Jinnaram MandaI, Sanga Reddy District, Telangana (Unit -1), from May 5, 2025 to May 9, 2025, with one observation. There is no impact on financial, operations or other activities of the company pursuant to the observation. 

SMS Lifesciences India is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, API and Intermediates.


  RELATED NEWS >>